VKTX vs. LLY
Compare and contrast key facts about Viking Therapeutics, Inc. (VKTX) and Eli Lilly and Company (LLY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VKTX or LLY.
Key characteristics
| VKTX | LLY | |
|---|---|---|
| YTD Return | 258.57% | 59.23% |
| 1Y Return | 344.87% | 57.18% |
| 3Y Return (Ann) | 119.38% | 60.11% |
| 5Y Return (Ann) | 56.43% | 55.02% |
| Sharpe Ratio | 2.28 | 1.82 |
| Daily Std Dev | 149.21% | 30.43% |
| Max Drawdown | -90.41% | -68.27% |
| Current Drawdown | -29.39% | -3.78% |
Fundamentals
| VKTX | LLY | |
|---|---|---|
| Market Cap | $6.96B | $831.73B |
| EPS | -$0.93 | $8.13 |
| PEG Ratio | -0.03 | 0.88 |
| Total Revenue (TTM) | $436.00K | $38.92B |
| Gross Profit (TTM) | $140.00K | $31.70B |
| EBITDA (TTM) | -$124.45M | $17.93B |
Correlation
The correlation between VKTX and LLY is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
VKTX vs. LLY - Performance Comparison
In the year-to-date period, VKTX achieves a 258.57% return, which is significantly higher than LLY's 59.23% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VKTX vs. LLY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Viking Therapeutics, Inc. (VKTX) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
VKTX vs. LLY - Dividend Comparison
VKTX has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.54%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VKTX Viking Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LLY Eli Lilly and Company | 0.54% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% | 2.84% | 3.84% |
Drawdowns
VKTX vs. LLY - Drawdown Comparison
The maximum VKTX drawdown since its inception was -90.41%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for VKTX and LLY. For additional features, visit the drawdowns tool.
Volatility
VKTX vs. LLY - Volatility Comparison
Viking Therapeutics, Inc. (VKTX) has a higher volatility of 25.01% compared to Eli Lilly and Company (LLY) at 6.56%. This indicates that VKTX's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
VKTX vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between Viking Therapeutics, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities